NYSBA Food, Drug & Cosmetic Law Section 2026 Annual Meeting

The NYSBA Food, Drug & Cosmetic Law Section 2026 Annual Meeting is a premier event organized by the New York State Bar Association's Food, Drug & Cosmetic Law Section. This gathering brings together legal professionals, industry experts, and policymakers to discuss and analyze current issues and developments in the food, drug, and cosmetic law sectors.

A key session at the meeting is the panel titled "Future of Vaccine Development – Will Restrictions Lead to Off Label Use?" This discussion will address the complexities arising from differing federal and state vaccine policies, as well as conflicting recommendations from the Advisory Committee on Immunization Practices (ACIP) and the Food and Drug Administration (FDA). The panel aims to explore how these policy discrepancies may impact vaccine access, administration practices, and the potential increase in off-label usage, ultimately influencing future vaccine availability and regulatory strategies.

The event will feature esteemed speakers, including Benjamin K. Wolf, a partner at Alston & Bird, who will share his insights on the aforementioned panel. Attendees will have opportunities to engage with experts, participate in in-depth discussions, and network with peers in the field.

This annual meeting is essential for legal practitioners, regulatory affairs professionals, and industry stakeholders involved in food, drug, and cosmetic law. It offers a platform to stay informed about the latest legal developments, understand emerging challenges, and collaborate on solutions to navigate the evolving regulatory landscape.